Cargando…
Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. These immune responses may be evaluated by measuring tumor-infiltrating lymphocytes (TILs), which has been frequently verified clinically. In the prese...
Autores principales: | Asano, Yuka, Kashiwagi, Shinichiro, Goto, Wataru, Takada, Koji, Takahashi, Katsuyuki, Shibutani, Masatsune, Amano, Ryosuke, Takashima, Tsutomu, Tomita, Shuhei, Hirakawa, Kosei, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366244/ https://www.ncbi.nlm.nih.gov/pubmed/32714546 http://dx.doi.org/10.3892/mco.2020.2063 |
Ejemplares similares
-
Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020) -
Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2018) -
Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
por: Takada, Koji, et al.
Publicado: (2022) -
Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020) -
Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)